A groundbreaking shift in the country's drug policy has taken place, as the regulators allow the availability of psilocybin hallucinogens for therapeutic treatment. Until now, these substances were severely restricted, but a mounting body of evidence suggests they may offer relief for emotional illnesses like depression. This change represents a ma